FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY

ÖZTÜRK, Güzin Zeren; Toprak, Dilek; ARDIÇ, Cüneyt

FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY

Cüneyt ARDIÇ, (2 Recep Tayyip Erdoğan University)

Dilek TOPRAK, (1 Sisli Hamidiye Etfal Training and Research Hospital)

Güzin Zeren ÖZTÜRK (1 Sisli Hamidiye Etfal Training and Research Hospital)

Türk Geriatri Dergisi

8 3

Yıl: 2017 Cilt: 20 Sayı: 4 Sayfa Aralığı: 296 - 305 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY

Öz:

Giriş: Yaşlanma, kronik hastalıklar ve ilaç kullanımını artırması polifarmasi görülme sıklığını artırmaktadır. Çalışmamızda, yaşlı bireylerde polifarmasi sıklığını, neden olan risk faktörlerinin ve ilaç kullanımının incelenmesi amaçlanmıştır. Gereç ve Yöntem: Aile hekimliği polikliniğine başvuran 300 (65 yaş üzeri) birey alındı. Sosyodemografik verilerin yanı sıra, mevcut ilaç kullanımı ile ilgili sorulardan oluşan bir anket uygulanmıştır. Halen kullanılan ilaçlar doktorlar tarafından listelenmiştir. Avrupa Birliği Potansiyel Uygun Olmayan İlaçlar listesine göre taranmıştır. Veriler ki-kare ve Student-t testleri kullanılarak analiz edildi; p <0.05 anlamlı kabul edildi. Bulgular: Çalışmada katılımcıların toplam 1.650 ilaç kullandıkları tespit edildi. Hasta başına düşen ortalama ilaç sayısı 5.50±2.84 (aralık 1-14) idi. Polifarmasi (>=5 ilaç) 187 (% 62.3) katılımcıda varken; Hiper polifarmasi (>=10 ilaç) ise 29 (%9.7) katılımcıda mevcuttu. Avrupa Birliği Potansiyel Uygun Olmayan İlaçlar listesinde olan 317 (% 19.2) ilaç vardı. 195 (% 65) hasta en az bir potansiyel olarak uygun olmayan ilaç kullanıyordu. Gereksiz kullanım nedeniyle toplam 124 (% 7.5) ilaç durduruldu. Hastalar için 108 (% 6.5) kullandığı ilaçlar nedeniyle dal doktorlar sevk edildi. Sonuç: Polifarmasi ve uygun olmayan ilaç kullanımı yaşlı bireylerde sık görülmektedir. Polifarmasi kronik hastalıklarla artarken; yakın doktor kontrolü ile azalmaktadır. Bu nedenle yaşlıda ilaç kullanımını değerlendirme önemli bir basamaktır

Anahtar Kelime:

Konular: Cerrahi

YAŞLILARDA POLİFARMASİNİN SIKLIĞI VE POTANSİYEL UYGUNSUZ İLAÇ KULLANIMI

Öz:

Introduction: Increased rates of increase in the elderly population, chronic illnesses and drugs usage are inevitable, making polypharmacy more frequent in older adults. Our study aimed to investigate the frequency of polypharmacy in the elderly and to examine their medication use.Materials and Method: Three hundred elderly individuals (aged >65 years) who visited our family medicine polyclinic were included in the study. In addition to collecting sociodemographic information, a questionnaire about current drug use was administered. Currently used drugs were listed by doctors and screened using screening tools. Data were analysed using the chi-square and Student’s t-tests; p < 0.05 was considered significant.Results: A total of 1,650 drugs were used by study participants. The mean number of drugs per patient was 5.50±2.84 (range, 1–14). Polypharmacy (≥5 drugs) was present in 187 (62.3%) participants; 5–9 drugs were used by 158 (52.7%). Hyperpolypharmacy (≥10 drugs) was present in 29 (9.7%) participants. In total, 317 (19.2%) drugs were on the list of the European Union Potentially Inappropriate Medications, and 195 (65%) patients were using at least one potentially inappropriate medication. A total of 124 (7.5%) medications were stopped due to unnecessary usage. Patients were referred to branch doctors because of 108 (6.5%) drugs.Conclusion: Polypharmacy and potentially inappropriate medication usage were both very frequent in this elderly population sample. Polypharmacy was positively related only to chronic diseases, negatively related to closely controlled therapy. For this reason, evaluation of drug use in the elderly is an important step

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Health Statistics 2015; Turkey Statistical Institute; 2016. [Internet] Available from: http://www.tuik.gov. tr/PreTablo.do?alt_id=1095. Accessed: 23.9.2017.
2. Merriam Webster Medical Dictionary. [Internet] Available from: https://www.merriam-webster.com/ dictionary/polypharmacy. Accessed: 23.9.2017.
3. Gnjidic D, Hilmer SN, Blyth FM, et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther 2012;91(3):521-8. (PMID:22297385).
4. Kojima T, Akishita M, Nakamura T, et al. Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatr Gerontl Int 2012;12(3):425-30. (PMID:22212467).
5. Institute of Medicine. Preventing medication errors. 2006. [Internet] Available from: http://www. Nationalacademies.org/hmd/w/media/Files/ Report%20Files/2006/PreventingMedication-ErrorsQuality-Chasm-Series/medicationerrorsnew.ashx. Accessed: 23.9.2017.
6. Levy HB, Marcus EL, Christen C. Beyond the Beers criteria: a comparative overview of explicit criteria. Ann Pharmacother 2010;44(12):1968‐75. (PMID:21081709).
7. Gallagher P, Ryan C, Byrne S, Kennedy J, Mahony D. STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008;46(2):72‐83. (PMID:18218287).
8. Renom-Guiteras A, Meyer G, Petra AT. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861-75. (PMID:25967540).
9. World Health Organisation (2017) Global Health Observatory (GHO) data. [Internet] Available from: http://www.who.int/gho/mortality_burden_disease/life_tables/situation_trends/en/.Accessed: 22.09.2017.
10. Turkey Statistical Institute (2016) Health statistics 2015. [Internet] Available from: http://www. turkstat.gov.tr/Start.do;jsessionid=JrzZZ3gKQsMntZM2Qsb8KyfvyfHmkvshyBGNCcl6T55hRXkH6sMc!560081250. Accessed: 22.9.2017.
11. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 2002;287(3):337-44.(PMID:11790213).
12. Qato DM, Alexander GC, Conti RM, et al. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs. 2011. JAMA Intern Med 2016;176:475-82. (PMID:19109115).
13-Santos TRA, Lima DM, Nakatani AYK, et al.Medicine use by the elderly in Goiania, Midwestern Brazil 2013;47(1):94-103. (PMID:23703135).
14. Pereira KG, Peres MA, Iop D, et al. Rev Bras Epidemiol 2017;20(2):335-44.(PMID:28832855).
15. Unsal A, Demir G. The prevalence of chronic disease and drug use in the elderly in central Kırsehir. Turkish Journal of Geriatrics 2010;13(4):244-51[Internet] Available from: http://geriatri.dergisi.org/pdf/pdf_ TJG_523.pdf. Accessed: 22.09.2017.
16. Park EJ, Sohn HS, Lee EK, Kwon JW. Living arrangements, chronic diseases, and prescription drug expenditures among Korean elderly: vulnerability to potential medication under use. BMC Public Health 2014;14(1):1284. (PMID:25516064).
17. Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging 2009;26(6):493- 503. (PMID:19591524).
18. McCracken R, McCormack J, McGregor MJ, Wong ST, Garrison S. Associations between polypharmacy and treatment intensity for hypertension and diabetes: a cross-sectional study of nursing home patients in British Columbia, Canada. BMJ Open 2017;7(8):7-8 doi: 10.1136/bmjopen-2017-017430 [Internet] Available from:http://bmjopen.bmj.com/ content/bmjopen/7/10/e017928.full.pdf. Accessed: 22.09.2017.
19. Badedi M, Solan Y, Darraj H, et al.Factors associated with long-term control of type 2 diabetes mellitus. J Diabetes Res 2016;2016:2109542. (PMID:28090538).
20. Hersh LR, Beldowski K, Hajjar ER. Polypharmacy in the geriatric oncology population. Curr Oncol Rep 2017;23;19(11):73. (PMID:28942563).
21. Hanigan MH, Dela Cruz BL, Thompson DM, Farmer KC, Medina PJ. Use of prescription and non-prescription medications and supplements by cancer patients during chemotherapy: questionnaire validation. J Oncol Pharm Pract 2008;14(3):123-30. (PMID:18719067).
22. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007;5(4):345-51. (PMID:18179993).
23. Grina D, Briedis V. The use of potentially inappropriate medications among the Lithuanian elderly according to Beers and EU(7)-PIM list - a nationwide cross-sectional study on reimbursement claims data. J Clin Pharm Ther 2017;42(2):195-200. (PMID:28155237).
24. Mucalo I, Hadžiabdić MO, Brajković A, et al. Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol. Eur J Clin Pharmacol 2017;73(8):991-9. (PMID:28405697).
25. Teklay G, Shiferaw N, Legesse B, Bekele ML. Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study. Thromb J 2014;12(1):20. (PMID:25249791).

APA	ARDIÇ C, Toprak D, ÖZTÜRK G (2017). FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY. , 296 - 305.
Chicago	ARDIÇ Cüneyt,Toprak Dilek,ÖZTÜRK Güzin Zeren FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY. (2017): 296 - 305.
MLA	ARDIÇ Cüneyt,Toprak Dilek,ÖZTÜRK Güzin Zeren FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY. , 2017, ss.296 - 305.
AMA	ARDIÇ C,Toprak D,ÖZTÜRK G FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY. . 2017; 296 - 305.
Vancouver	ARDIÇ C,Toprak D,ÖZTÜRK G FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY. . 2017; 296 - 305.
IEEE	ARDIÇ C,Toprak D,ÖZTÜRK G "FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY." , ss.296 - 305, 2017.
ISNAD	ARDIÇ, Cüneyt vd. "FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY". (2017), 296-305.

APA	ARDIÇ C, Toprak D, ÖZTÜRK G (2017). FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY. Türk Geriatri Dergisi, 20(4), 296 - 305.
Chicago	ARDIÇ Cüneyt,Toprak Dilek,ÖZTÜRK Güzin Zeren FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY. Türk Geriatri Dergisi 20, no.4 (2017): 296 - 305.
MLA	ARDIÇ Cüneyt,Toprak Dilek,ÖZTÜRK Güzin Zeren FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY. Türk Geriatri Dergisi, vol.20, no.4, 2017, ss.296 - 305.
AMA	ARDIÇ C,Toprak D,ÖZTÜRK G FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY. Türk Geriatri Dergisi. 2017; 20(4): 296 - 305.
Vancouver	ARDIÇ C,Toprak D,ÖZTÜRK G FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY. Türk Geriatri Dergisi. 2017; 20(4): 296 - 305.
IEEE	ARDIÇ C,Toprak D,ÖZTÜRK G "FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY." Türk Geriatri Dergisi, 20, ss.296 - 305, 2017.
ISNAD	ARDIÇ, Cüneyt vd. "FREQUENCY OF POLYPHARMACY AND USE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN THE ELDERLY". Türk Geriatri Dergisi 20/4 (2017), 296-305.